Evidence map›Paper›PMID 34661520›Full record

ArticleMicrobiology (Reading, England)2021

Alan F Scott, Evelyne Deery, Andrew D Lawrence, Martin J Warren

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology (Reading, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Alan F ScottSchool of Biosciences, University of Kent, Canterbury, Kent, CT2 7NJ, UK.
Evelyne DeerySchool of Biosciences, University of Kent, Canterbury, Kent, CT2 7NJ, UK.
Andrew D LawrenceSchool of Biosciences, University of Kent, Canterbury, Kent, CT2 7NJ, UK.
Martin J WarrenSchool of Biosciences, University of Kent, Canterbury, Kent, CT2 7NJ, UK.
University of Kent · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Uroporphyrinogen III, the universal progenitor of macrocyclic, modified tetrapyrroles, is produced from aminolaevulinic acid (ALA) by a conserved pathway involving three enzymes: porphobilinogen synthase (PBGS), hydroxymethylbilane synthase (HmbS) and uroporphyrinogen III synthase (UroS). The gene encoding uroporphyrinogen III synthase has not yet been identified in

Indexed as

Biosynthetic PathwaysEscherichia coliGenetic Complementation TestHemeHydroxymethylbilane SynthaseMutationPlasmodium falciparumProtozoan ProteinsUroporphyrinogen III SynthetaseUroporphyrinogensHemeHydroxymethylbilane SynthaseProtozoan ProteinsUroporphyrinogen III SynthetaseUroporphyrinogenshaem synthesishydroxymethylbilanePlasmodium falciparumporphobilinogen deaminaseuroporphyrinogen III

Identifiers

PMID34661520
PMCPMC8698207
OpenAlexW3207090074

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.